Founded  by a group of accomplished biopharmaceutical professionals who have  collaborated extensively on early-stage drug discovery and development  projects.  

 PHT  has the resources to identify  strong preclinical therapeutic  opportunities with addressable markets, valid science, druggable  targets, and clear regulatory precedent. 

The Company's strong business  model, its core leadership and drug development team enable efficient  use of resources and capital, and creation of strong IP leading to early  clinical proof-of-concept and successful exits.